News | Mammography | September 28, 2015

Editorial responds to study finding computed-aided detection did not improve, and even hampered, cancer detection in mammograms

UC Davis, Joshua Fenton, computer-aided diagnosis, mammograms, breast cancer, Constance D. Lehman

September 28, 2015 — A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues Joshua Fenton, a family physician and comparative effectiveness researcher. Fenton’s editorial on the subject was published online Sept. 25 in the Journal of the American Medical Association Internal Medicine.

Fenton’s editorial responds to a study published in the same issue that announces findings from the largest study ever on computer-aided detection (CAD), a tool approved by the U.S. Food and Drug Administration nearly 20 years ago to help radiologists interpret screening mammograms by automatically marking potentially suspicious spots for further radiological review.

The study was led by Constance D. Lehman, M.D., Ph.D., currently director of breast imaging and co-director of the Avon Comprehensive Breast Evaluation Center at Massachusetts General Hospital in Boston, who conducted the research while at the University of Washington in Seattle. University of California Davis Dean’s Professor in Biostatistics Diana Miglioretti was senior author on the study, which found that CAD used with mammography did not improve the accuracy of diagnosis, and that its use may in fact result in missed cancers.

“The study by Lehman, et al., provides evidence that CAD yields no clear benefits in a large, diverse U.S. sample of women undergoing digital mammography,” Fenton wrote. “Thus we should question whether society should continue to pay for CAD use.”

Using data from the Breast Cancer Surveillance Consortium, Lehman’s observational study looked at 323,973 women undergoing digital screening mammography in diverse U.S. practices between 2003 and 2009. Mammograms were interpreted by 271 radiologists from 66 facilities. Tumor registry data identified 3,159 breast cancers within one year of screening.

For the study, the researchers analyzed the mammography performance, including its sensitivity (the proportion of cancers positively detected), specificity (the proportion of accurate negative findings), the number of cancers detected during mammography and those discovered within 12 months of a negative mammogram finding. They found that screening performance was not improved with CAD on any one of the assessed metrics. In fact, they found that sensitivity was significantly decreased for mammograms interpreted with CAD among radiologists who interpreted results with and without the added technology.

In the editorial, Fenton, who also has published several research articles about the merits of CAD, said any potential positive effects of CAD may be undetectable in the context of digital mammography, which may improve the radiologist’s interpretation regardless of CAD.

Since Medicare agreed to cover the cost of CAD in 2000, its use has surged to over 90 percent of U.S. mammograms. Lehman estimated that its prolific use adds up to more than $400 million per year, or $1 of every $10,000 spent on healthcare.

Miglioretti, who was senior author on the Lehman study and has a joint appointment as a senior investigator at Group Health Research Institute, said the results of the CAD research suggest that federal regulators and payers should base coverage determinations on facts.

“We need to make sure there is stronger evidence for new technologies before we start paying for them,” she said, “and before people are charged extra money for them.”

For more information: www.ucdmc.ucdavis.edu/cancer


Related Content

News | Breast Imaging

July 8, 2025 — QT Imaging Holdings, has appointed Elaine Iuanow, MD, as chief medical officer (CMO) and Kim Du as senior ...

Time July 09, 2025
arrow
News | Breast Imaging

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Time July 08, 2025
arrow
News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Women's Health

June 23, 2025 — Susan G. Komen, the world’s leading breast cancer organization, recently announced it is awarding $10.8 ...

Time June 23, 2025
arrow
Feature | Women's Health | Christine Murray

In breast cancer detection, speed and accuracy are more than clinical goals – they can significantly increase chances ...

Time June 17, 2025
arrow
News | PET Imaging

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...

Time May 30, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
Subscribe Now